These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 4136728)

  • 21. [Mechanism of action of psychotropic drugs].
    Kanig K
    Hippokrates; 1974 May; 45(2):181-202. PubMed ID: 4152489
    [No Abstract]   [Full Text] [Related]  

  • 22. Stress-related effects of various inhibitors of catecholamine synthesis in the mouse.
    Thornburg JE; Moore KE
    Arch Int Pharmacodyn Ther; 1971 Nov; 194(1):158-67. PubMed ID: 4399378
    [No Abstract]   [Full Text] [Related]  

  • 23. Evidence for a dopaminergic dominance in the 4,alpha-dimethyl-m-tyramine-induced hypermotility in mice.
    Rüdeberg C
    Psychopharmacology (Berl); 1978 Dec; 59(3):247-54. PubMed ID: 32571
    [No Abstract]   [Full Text] [Related]  

  • 24. The pharmacologic meaning of successful antipsychotic-antidepressant combinations.
    Extein I; Bowers MB
    Compr Psychiatry; 1975; 16(5):427-34. PubMed ID: 240642
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhibition of tyrosine hydroxylase but not dopamine-beta-hydroxylase facilitates the action of behaviourally ineffective doses of neuroleptics.
    Antelman SM; Szechtman H; Chin P; Fisher AE
    J Pharm Pharmacol; 1976 Jan; 28(1):66-8. PubMed ID: 6656
    [No Abstract]   [Full Text] [Related]  

  • 26. Antipsychotic drugs and catecholamine synapses. Summary of the session.
    Andén NE
    J Psychiatr Res; 1974; 11():97-104. PubMed ID: 4156797
    [No Abstract]   [Full Text] [Related]  

  • 27. Inhibition of 4,alpha-dimethyl-m-tyramine (H 77/77)-induced hypermotility in rats by single and repeated administration of chloropromazine, haloperidol, clozapine and thioridazine.
    Buus Lassen J
    Psychopharmacologia; 1975 Jul; 43(1):25-9. PubMed ID: 51502
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dopaminergic mediation of the interoceptive cue produced by d-amphetamine in rats.
    Schechter MD; Cook PG
    Psychopharmacologia; 1975 May; 42(2):185-93. PubMed ID: 240181
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Shock-induced locomotor excitation following acute and chronic amphetamine treatment.
    Kokkinidis L; Irwin J; Anisman H
    Neuropharmacology; 1979 Jan; 18(1):13-22. PubMed ID: 33347
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the accumulation of O-methylated dopamine and noradrenaline in the rat brain following various neuroleptics, thymoleptics and aceperone.
    Scheel-Krüger J
    Arch Int Pharmacodyn Ther; 1972 Feb; 195(2):372-8. PubMed ID: 5015941
    [No Abstract]   [Full Text] [Related]  

  • 31. Amfonelic acid, a non-amphetamine stimulant, has marked effects on brain dopamine metabolism but not noradrenaline metabolism: association with differences in neuronal storage systems.
    McMillen BA; Shore PA
    J Pharm Pharmacol; 1978 Jul; 30(7):464-6. PubMed ID: 27622
    [No Abstract]   [Full Text] [Related]  

  • 32. Central catecholamine neurons, behavior and neuroleptic drugs: an analysis to understand the involvement of catecholamines in schizophrenia.
    Fuxe K; Nyström M; Tovi M; Smith R; Ogren SO
    J Psychiatr Res; 1974; 11():151-61. PubMed ID: 4156786
    [No Abstract]   [Full Text] [Related]  

  • 33. Phenothiazines and other tranquilizers.
    Lear E
    Clin Anesth; 1974; 10(1):185-206. PubMed ID: 4149701
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparison of the behavioral depressant effects of biogenic amine depleting and neuroleptic agents following various 6-hydroxydopamine treatments.
    Cooper BR; Grant LD; Breese GR
    Psychopharmacologia; 1973 Jul; 31(2):95-109. PubMed ID: 4722209
    [No Abstract]   [Full Text] [Related]  

  • 35. [Methodical problems of psychopharmacology presented using the example of antidepressive agents].
    Hoffmeister F
    Arzneimittelforschung; 1969 May; 19(5):808-10. PubMed ID: 5819796
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of Org 6582, chlorimipramine and desmethylimipramine on the depletion of biogenic amines from the rat brain in vivo.
    Kafoe WF; Leonard BE
    Biochem Pharmacol; 1977 Jun; 26(11):1083-4. PubMed ID: 880260
    [No Abstract]   [Full Text] [Related]  

  • 37. The effect of a new tetracyclic anti-depressant compound, Org GB 94, on the turnover of dopamine, noradrenalin and serotonin in the rat brain.
    Kafoe WF; Leonard BE
    Arch Int Pharmacodyn Ther; 1973 Dec; 206(2):389-91. PubMed ID: 4778631
    [No Abstract]   [Full Text] [Related]  

  • 38. Evidence of a role for brain monoamines in ethanol dependence.
    Griffiths PJ; Littleton JM; Oritz A; Brownlee G
    Br J Pharmacol; 1973 Jun; 48(2):354P. PubMed ID: 4147432
    [No Abstract]   [Full Text] [Related]  

  • 39. Release of dopamine from central noradrenaline and dopamine nerves induced by a dopamine-beta-hydroxylase inhibitor.
    Andén NE; Atack CV; Svensson TH
    J Neural Transm; 1973; 34(2):93-100. PubMed ID: 4722575
    [No Abstract]   [Full Text] [Related]  

  • 40. Some effects of a new tetracyclic anti-depressant compound, Org GB 94, on the metabolism of monoamines in the rat brain.
    Leonard BE
    Psychopharmacologia; 1974 Apr; 36(3):221-36. PubMed ID: 4846327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.